Serotonin levels in platelet-poor plasma and whole blood from healthy subjects: Relationship with lipid markers and coronary heart disease risk score

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 10, 2011, Pages 874-882

  Hirowatari, Yuji ^a   Hara, Katsuko ^b   Shimura, Yuko ^a   Takahashi, Hakuo ^b  

^a TOSOH CORPORATION   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Biomarker; High performance liquid chromatography; Platelet actiation

Indexed keywords

BIOLOGICAL MARKER; CHYLOMICRON; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEROTONIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MALE; METABOLIC DISORDER; NORMAL HUMAN; RISK ASSESSMENT; SEROTONIN BLOOD LEVEL; SMOKING; THROMBOCYTE POOR PLASMA;

ADULT; BIOLOGICAL MARKERS; BLOOD PLATELETS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY DISEASE; HUMANS; LIPIDS; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; SEROTONIN;

EID: 80055114532     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.8995     Document Type: Article

References (32)

1. May AE, Seizer P, Gawaz M: Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol, 2008; 28: s5-10
2. Gawaz M, Langer H, May AE: Platelets in inflammation and atherogenesis. J Clin Invest, 2005; 115: 3378-3384
3. Schulz C, Schafer A, Stolla M, Kerstan S, Lorenz M, von Bruhl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, Gawaz M, Massberg S: Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation, 2007; 116: 764-773
4. Ohkawa R, Hirowatari Y, Nakamura K, Ohkubo S, Ikeda H, Okada M, Tozuka M, Nakahara K, Yatomi Y: Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. Clin Biochem, 2005; 38: 1023-1026
5. Hara K, Hirowatari Y, Yoshika M, Komiyama Y, Tsuka Y, Takahashi H: The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular disease. J Lab Clin Med, 2004; 144: 31-37
6. Figueras J, Domingo E, Cortadellas J, Padilla F, Dorado DG, Segura R, Galard R, Soler JS: Comparison of plasma serotonin levels in patients with variant angina pectoris versus healed myocardial infarction. Am J Cardiol, 2005; 96: 204-207
7. Fareed J, Hoppensteadt DA, Leya F, Iqbal O, Wolf H, Bick R: Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Clin Chem, 1998; 44: 1845-1853
8. Lusis AJ: Atherosclerosis. Nature, 2000; 407: 233-241
9. Siegel-Axel D, Daub K, Seizer P, Lindemann S, Gawaz M: Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res, 2008; 78: 8-17
10. Korporaal SJ, Akkerman JW: Platelet activation by low density lipoprotein and high density lipoprotein. Pathophysiol Haemost Thromb, 2006; 35: 270-280
11. Koller E, Volf I, Gurvitz A, Koller F: Modified low-density lipoproteins and high-density lipoproteins. From investigation tools to real in vivo players. Pathophysiol Haemost Thromb, 2006; 35: 322-345
12. Chen R, Chen X, Salomon RG, McIntyre TM: Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor. Arterioscler Thromb Vasc Biol, 2009; 29: 363-371
13. Pfennig O, Zhao B, Frye S, Dierichs R: High-density lipoprotein fails to inhibit serotonin-induced activation of blood platelets. Am J Hematol, 1995; 50: 307-309
14. Desai K, Bruckdorfer KR, Hutton RA, Owen JS: Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation. J Lipid Res, 1989; 30: 831-840
15. Hassall DG, Owen JS, Bruckdorfer KR: The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Biochem J, 1983; 216: 43-49
16. Tagari PC, Boullin DJ, Davies CL: Simplified determination of serotonin in plasma by liquid chromatography with electrochemical detection. Clin Chem, 1984; 30: 131-135
17. Picard M, Olichon D, Gombert J: Determination of serotonin in plasma by liquid chromatography with electrochemical detection. J Chromatogr, 1985; 341: 445-451
18. Eriksson BM, Persson BA: Determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in plasma by direct injection in coupled-column liquid chromatography with electrochemical detection. J Chromatogr, 1988; 459: 351-360
19. Takkenberg B, Endert E, van Ingen HE, Ackermans M: Improved method for the determination of serotonin in plasma by high-performance liquid chromatography using on-line sample pre-treatment. J Chromatogr, 1991; 565: 430-435
20. Pussard E, Guigueno N, Adam O, Giudicelli JF: Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine. Clin Chem, 1996; 42: 1086-1091
21. Winocour PH, Klimiuk P, Grennan A, Baker RD, Weinkove C: Platelet and plasma vasoactive amines in type 1 (insulin-dependent) diabetes mellitus with and without vascular disease. Ann Clin Biochem, 1990; 27: 238-243
22. Hirowatari Y, Hara K, Kamihata H, Iwasaka T, Takahashi H: High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. Clin Biochem, 2004; 37: 191-197
23. Hirowatari Y, Yoshida H, Kurosawa H, Doumitu KI, Tada N: Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J Lipid Res, 2003; 44: 1404-1412
24. Hirowatari Y, Yoshida H, Fueki Y, Ito M, Ogura Y, Sakurai N, Miida T: Measurement of cholesterol concentrations of major serum lipoprotein classes in haemodialysis patients by anion-exchange chromatography. Ann Clin Biochem, 2008; 45: 571-574
25. Yoshida H, Ishikawa T, Suto M, Kurosawa H, Hirowatari Y, Ito K, Yanai H, Tada N, Suzuki M: Effects of supervised aerobic exercise training on serum adiponectin and parameters of lipid and glucose metabolism in subjects with moderate dyslipidemia. J Atheroscler Thromb, 2010; 17: 1160-1166
26. Wilson PW, D' Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97: 1837-1847
27. de Jong WH, Wilkens MH, de Vries EG, Kema IP: Automated mass spectrometric analysis of urinary and plasma serotonin. Anal Bioanal Chem, 2010; 396: 2609-2616
28. Relou AM, Gorter G. van Rijn HJ, Akkerman JW: Platelet activation by the apoB/E receptor-binding domain of LDL. Thromb Haemost, 2002; 87: 880-887
29. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR: Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest, 1996; 97: 2917-2923
30. Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, Ishigami M, Sakai N, Kameda-Takemura K, Matsuzawa Y: Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol, 1997; 17: 1053-1059
31. Topsakal R, Kalay N, Gunturk EE, Dogan A, Inanc MT, Kaya MG, Ergin A, Yarlioglues M: The relation between serotonin levels and insufficient blood pressure decrease during night-time in hypertensive patients. Blood Press, 2009; 18: 367-371
32. Pietraszek MH, Takada Y, Takada A, Fujita M, Watanabe I, Taminato A, Yoshimi T: Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus. Thromb Res, 1992; 66: 765-774